|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Rethinking the Economics of Chromatography: New Technologies and Hidden Costs
Author(s)Tim N. Warner, Sam Nuchumson
by Tim N. Warner and Sam Nuchumson, Pall Life Sciences If the hidden expenses associated with laboratory purchases ? labor, cleaning, buffers, validation, time delays ? are identified, reduced processing costs, higher throughput, and accelerated time-to-market are possible. This comparison between resin and membrane chromatography helps shed light on some hidden costs.
Advertisement
Articles in this issue
almost 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mousealmost 23 years ago
Guest Editorial: At the Governance Crossroadalmost 23 years ago
Reducing Costs by Facility Designalmost 23 years ago
Guidelines for Optimization and Scale-Up in Preparative Chromatographyalmost 23 years ago
Survival Strategies: Board Compensation Changing with the TimesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
3
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
4
A Step-by-Step Approach for Method Development to Generate a Successful HILIC Separation
5
